Salbutamol

Indications retenues par l’OMS

Asthme ; bronchopneumopathie chronique obstructive (BPCO).

Formes et dosages listés

• Parenteral > General injections > IV: 500 µg per mL in 1 mL ampoule (as sulfate); 500 µg per mL in 5 mL ampoule (as sulfate)
• Respiratory > Inhalation > solution: 100 µg per actuation in pressurized metered dose inhaler (as sulfate); 2.5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers; 5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers; 5 mg per mL in multi-dose bottle (as sulfate) for use in nebulizers

Formes retenues dans la liste modèle ; les présentations disponibles dans chaque pays peuvent différer.